Nab-paclitaxel is a chemotherapeutic drug used to treat various solid malignant tumors. It was conceived with a solvent free formulation to overcome toxicity events and hypersensitivity reactions associated with paclitaxel. However, it still carries ocular adverse effects. The present review examines nab-paclitaxel related cystoid macular edema (CME) and the available therapeutic options
Cystoid macular edema (CME) is a classical complication of ocular inflammation. This syndrome was al...
The article considers the place of nab-paclitaxel in the treatment of metastatic breast cancer. A nu...
Cataract surgery is an efficient procedure, and is generally associated with good visual results. Ne...
Paclitaxel is a member of the taxane agents that has demonstrated efficacy in ovarian cancer, both i...
Drug-induced cystoid macular edema (CME) is a rare ophthalmologic finding in patients taking paclita...
Cystoid macular edema (CME) is a rare side effect associated with chemotherapy. Although the develop...
Macular edema is a condition that is usually secondary to an underlying disease and that causes seve...
Paclitaxel is well known for its treatment effect on meta-static breast cancer. To date, various sid...
Cystoid macular edema is rarely observed secondary to paclitaxel treatment. A 55-year-old female pat...
Copyright © 2015 Naoki Matsuoka et al.This is an open access article distributed under theCreativeCo...
Abstract Background Cystoid macular edema is a rare, vision-threatening side effect of the taxane fa...
Taxanes are highly active chemotherapeutic agents in the treatment of early-stage and metastatic bre...
Introduction: Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) is a novel solvent-free formula...
Cystoid macular edema is a common cause for unexplained painless vision loss after cataract surgery....
Purpose: To report the clinical presentation, multimodal imaging, and management of a patient with m...
Cystoid macular edema (CME) is a classical complication of ocular inflammation. This syndrome was al...
The article considers the place of nab-paclitaxel in the treatment of metastatic breast cancer. A nu...
Cataract surgery is an efficient procedure, and is generally associated with good visual results. Ne...
Paclitaxel is a member of the taxane agents that has demonstrated efficacy in ovarian cancer, both i...
Drug-induced cystoid macular edema (CME) is a rare ophthalmologic finding in patients taking paclita...
Cystoid macular edema (CME) is a rare side effect associated with chemotherapy. Although the develop...
Macular edema is a condition that is usually secondary to an underlying disease and that causes seve...
Paclitaxel is well known for its treatment effect on meta-static breast cancer. To date, various sid...
Cystoid macular edema is rarely observed secondary to paclitaxel treatment. A 55-year-old female pat...
Copyright © 2015 Naoki Matsuoka et al.This is an open access article distributed under theCreativeCo...
Abstract Background Cystoid macular edema is a rare, vision-threatening side effect of the taxane fa...
Taxanes are highly active chemotherapeutic agents in the treatment of early-stage and metastatic bre...
Introduction: Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) is a novel solvent-free formula...
Cystoid macular edema is a common cause for unexplained painless vision loss after cataract surgery....
Purpose: To report the clinical presentation, multimodal imaging, and management of a patient with m...
Cystoid macular edema (CME) is a classical complication of ocular inflammation. This syndrome was al...
The article considers the place of nab-paclitaxel in the treatment of metastatic breast cancer. A nu...
Cataract surgery is an efficient procedure, and is generally associated with good visual results. Ne...